Clinical Insights Into the Use of Speech Amplification Devices for Managing Hypophonia: Interviews With Speech-Language Pathologists

被引:0
作者
Gates, Kelly [1 ]
Knowles, Thea [2 ]
Mach, Helen [3 ]
Higginbotham, Jeff [1 ]
Patel, Rita R.
Symptoms, Speech
机构
[1] Univ Buffalo, Dept Commun Disorders & Sci, Buffalo, NY USA
[2] Michigan State Univ, Dept Commun Sci & Disorders, E Lansing, MI 48824 USA
[3] Univ Delaware, Dept Commun Sci & Disorders, Newark, NJ USA
关键词
PROGRESSIVE SUPRANUCLEAR PALSY; PARKINSONS-DISEASE; VOICE TREATMENT; MOTOR; INTELLIGIBILITY; IMPAIRMENT; INDIVIDUALS; PERFORMANCE; PREVALENCE; INTENSITY;
D O I
10.1044/2024_AJSLP-23-00396
中图分类号
R36 [病理学]; R76 [耳鼻咽喉科学];
学科分类号
100104 ; 100213 ;
摘要
Purpose: The purpose of this qualitative interview study was to identify themes regarding considerations in the usage of speech amplification device usage for people with Parkinson's disease (PD) and hypophonia from the perspective of speech-language pathologists (SLPs). Method: Eligible participants included SLPs currently practicing in the United States or Canada with experience working with clients with PD for at least 2 years. Ten SLPs participated in 60-min interviews conducted via Zoom. A semistructured interview guide was created prior to the interviews. The interviews were transcribed following their completion, and an iterative coding process was used to identify themes using thematic analysis. Results: Three main themes were identified from the interviews. The first theme encapsulated how clinicians described amplification devices as a potential treatment tool, which highlighted the nuances that may impact selecting an amplification device as a treatment option such as increased hypophonia or dysarthria severity and cognitive decline. The second theme highlighted how device selection depends on the individual needs of the user. Individual client characteristics (such as disease symptoms and individual needs and preferences) may impact the choice of amplification device. The last theme outlined the importance of involving family members in all stages of device use and involving other health care team members on a case-by-case basis. Conclusions: The insights provided by the SLP participants help to understand the clinical decisions that are made when determining device candidacy, selecting a device, and evaluating device success. These insights can be used to improve research studies of augmentative management of hypophonia and guide more personalized management decisions.
引用
收藏
页码:1639 / 1661
页数:23
相关论文
共 77 条
  • [1] Cognitive decline in Parkinson disease
    Aarsland, Dag
    Creese, Byron
    Politis, Marios
    Chaudhuri, K. Ray
    Ffytche, Dominic H.
    Weintraub, Daniel
    Ballard, Clive
    [J]. NATURE REVIEWS NEUROLOGY, 2017, 13 (04) : 217 - 231
  • [2] Adams S.C., 2009, Clinical Management of Sensorimotor Speech Disorders, V2nd, P166, DOI [10.1007/978-1-62703-556-9, DOI 10.1007/978-1-62703-556-9]
  • [3] Adams S.G., 2005, Canadian Acoustics, V33, P94
  • [4] Adams S.G., 2008, Journal of Medical Speech-Language Pathology, V16, P165
  • [5] Adams SG, 2002, J MED SPEECH-LANG PA, V10, P215
  • [6] ADAMS SG, 1992, EUR J DISORDER COMM, V27, P121
  • [7] American Speech-Language-Hearing Association, 2004, Evidencebased practice in communication disorders Position statement
  • [8] American Speech-Language-Hearing Association, 2004, Evidence-Based Practice in Communication Disorders: An Introduction
  • [9] Listener Perception of Monopitch, Naturalness, and Intelligibility for Speakers With Parkinson's Disease
    Anand, Supraja
    Stepp, Cara E.
    [J]. JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH, 2015, 58 (04): : 1134 - 1144
  • [10] Evaluation of Speech Amplification Devices in Parkinson's Disease
    Andreetta, Monika D.
    Adams, Scott G.
    Dykstra, Allyson D.
    Jog, Mandar
    [J]. AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY, 2016, 25 (01) : 29 - 45